ohr pharmaceutical inc (OHRP:NASDAQ CM)
ohr pharmaceutical inc (OHRP) Snapshot
|
Open
$8.04
|
Previous Close
$8.00
|
|
|
Day High
$8.05
|
Day Low
$8.01
|
|
|
52 Week High
06/13/13 - $8.50
|
52 Week Low
06/22/12 - $2.25
|
|
|
Market Cap
144.5M
|
Average Volume 10 Days
11.0K
|
|
|
EPS TTM
$-0.21
|
Shares Outstanding
18.0M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
ohr pharmaceutical inc (OHRP) Related Businessweek News
No Related Businessweek News Foundohr pharmaceutical inc (OHRP) Details
OHR Pharmaceutical, Inc. operates as a biotechnology company. The company’s product line includes Squalamine, an anti-angiogenic small molecule with a novel intracellular mechanism of action that inhibits vascular endothelial, platelet derived and basic fibroblast growth factors for the treatment of the wet form of age-related macular degeneration. It also offers OHR/AVR 118, which is in Phase II clinical trial for the treatment of cancer cachexia, a multi-symptom wasting disorder characterized by weight loss, muscle atrophy, fatigue, weakness, and significant loss of appetite. The company is headquartered in New York, New York.
Last Reported Date: 01/9/13
ohr pharmaceutical inc (OHRP) Top Compensated Officers
ohr pharmaceutical inc (OHRP) Key Developments
Ohr Pharmaceutical, Inc. will be added to NASDAQ Composite Index.
On May 29, 2013, Ohr Pharmaceutical, Inc. filed an Amendment to the company's Articles of Incorporation with the Delaware Secretary of State to effect a 1-for-3 reverse stock split of the company's common stock, to be effective on June 3, 2013. As a result of the reverse stock split, every three shares of the Company's issued and outstanding common stock will be combined into one share of common stock and any fractional shares created by the reverse stock split will be rounded up to the nearest whole share. The reverse stock split will be effective as of 9:00 a.m. on June 3, 2013.
Effective June 03, 2013, Ohr Pharmaceutical, Inc. will change its Pink Sheets LLC stock ticker symbol to OHRPD from OHRP.
| Recently Viewed | |||
| OHRP:US | $8.02 USD | +0.0234 |  |
| Company | Last | Change | |
| No competitor information is available for OHRP. | |||
| View Industry Companies | |||
Industry Analysis
OHRP
Industry Average
| Valuation | OHRP | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | -- | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact OHR PHARMACEUTICAL INC, please visit www.ohrpharmaceutical.net. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
